213 related articles for article (PubMed ID: 26646771)
1. Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.
Miller MC; Ippel H; Suylen D; Klyosov AA; Traber PG; Hackeng T; Mayo KH
Glycobiology; 2016 Jan; 26(1):88-99. PubMed ID: 26646771
[TBL] [Abstract][Full Text] [Related]
2. NMR-based insight into galectin-3 binding to endothelial cell adhesion molecule CD146: Evidence for noncanonical interactions with the lectin's CRD β-sandwich F-face.
Zhang Z; Miller MC; Xu X; Song C; Zhang F; Zheng Y; Zhou Y; Tai G; Mayo KH
Glycobiology; 2019 Jul; 29(8):608-618. PubMed ID: 31094416
[TBL] [Abstract][Full Text] [Related]
3. Structural features for α-galactomannan binding to galectin-1.
Miller MC; Klyosov AA; Mayo KH
Glycobiology; 2012 Apr; 22(4):543-51. PubMed ID: 22156919
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation.
Zhao Z; Xu X; Cheng H; Miller MC; He Z; Gu H; Zhang Z; Raz A; Mayo KH; Tai G; Zhou Y
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952698
[TBL] [Abstract][Full Text] [Related]
5. Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.
Miller MC; Zheng Y; Yan J; Zhou Y; Tai G; Mayo KH
Glycobiology; 2017 Nov; 27(11):1038-1051. PubMed ID: 28973299
[TBL] [Abstract][Full Text] [Related]
6. The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.
Miller MC; Klyosov A; Mayo KH
Glycobiology; 2009 Sep; 19(9):1034-45. PubMed ID: 19541770
[TBL] [Abstract][Full Text] [Related]
7. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner.
Berbís MÁ; André S; Cañada FJ; Pipkorn R; Ippel H; Mayo KH; Kübler D; Gabius HJ; Jiménez-Barbero J
Biochem Biophys Res Commun; 2014 Jan; 443(1):126-31. PubMed ID: 24269589
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 binds selectively to the terminal, non-reducing end of β(1→4)-galactans, with overall affinity increasing with chain length.
Miller MC; Zheng Y; Zhou Y; Tai G; Mayo KH
Glycobiology; 2019 Jan; 29(1):74-84. PubMed ID: 30204870
[TBL] [Abstract][Full Text] [Related]
9. The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.
Miller MC; Nesmelova IV; Platt D; Klyosov A; Mayo KH
Biochem J; 2009 Jun; 421(2):211-21. PubMed ID: 19432560
[TBL] [Abstract][Full Text] [Related]
10. Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.
Ippel H; Miller MC; Vértesy S; Zheng Y; Cañada FJ; Suylen D; Umemoto K; Romanò C; Hackeng T; Tai G; Leffler H; Kopitz J; André S; Kübler D; Jiménez-Barbero J; Oscarson S; Gabius HJ; Mayo KH
Glycobiology; 2016 Aug; 26(8):888-903. PubMed ID: 26911284
[TBL] [Abstract][Full Text] [Related]
11. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.
Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC
Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013
[TBL] [Abstract][Full Text] [Related]
12. Macromolecular assemblies of complex polysaccharides with galectin-3 and their synergistic effects on function.
Zhang T; Miller MC; Zheng Y; Zhang Z; Xue H; Zhao D; Su J; Mayo KH; Zhou Y; Tai G
Biochem J; 2017 Nov; 474(22):3849-3868. PubMed ID: 28986508
[TBL] [Abstract][Full Text] [Related]
13. Glycan dependence of Galectin-3 self-association properties.
Halimi H; Rigato A; Byrne D; Ferracci G; Sebban-Kreuzer C; ElAntak L; Guerlesquin F
PLoS One; 2014; 9(11):e111836. PubMed ID: 25369125
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
Bian CF; Zhang Y; Sun H; Li DF; Wang DC
PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
[TBL] [Abstract][Full Text] [Related]
16. Understanding the specificity of human Galectin-8C domain interactions with its glycan ligands based on molecular dynamics simulations.
Kumar S; Frank M; Schwartz-Albiez R
PLoS One; 2013; 8(3):e59761. PubMed ID: 23555773
[TBL] [Abstract][Full Text] [Related]
17. Targeting the CRD F-face of Human Galectin-3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative.
Miller MC; Zheng Y; Suylen D; Ippel H; Cañada FJ; Berbís MA; Jiménez-Barbero J; Tai G; Gabius HJ; Mayo KH
ChemMedChem; 2021 Feb; 16(4):713-723. PubMed ID: 33156953
[TBL] [Abstract][Full Text] [Related]
18. The second glutamic acid in the C-terminal CRD affects the carbohydrate-binding properties of recombinant galectins of Haemonchus contortus.
Wang J; Yan R; Xu L; Li X
Vet Parasitol; 2007 Sep; 148(3-4):247-55. PubMed ID: 17643820
[TBL] [Abstract][Full Text] [Related]
19. The water network in galectin-3 ligand binding site guides inhibitor design.
Su J; Zhang T; Wang P; Liu F; Tai G; Zhou Y
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):192-8. PubMed ID: 25662390
[TBL] [Abstract][Full Text] [Related]
20. Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.
Stegmayr J; Lepur A; Kahl-Knutson B; Aguilar-Moncayo M; Klyosov AA; Field RA; Oredsson S; Nilsson UJ; Leffler H
J Biol Chem; 2016 Jun; 291(25):13318-34. PubMed ID: 27129206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
